Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9648929rdf:typepubmed:Citationlld:pubmed
pubmed-article:9648929lifeskim:mentionsumls-concept:C0597694lld:lifeskim
pubmed-article:9648929lifeskim:mentionsumls-concept:C0205245lld:lifeskim
pubmed-article:9648929lifeskim:mentionsumls-concept:C0086982lld:lifeskim
pubmed-article:9648929lifeskim:mentionsumls-concept:C1948027lld:lifeskim
pubmed-article:9648929lifeskim:mentionsumls-concept:C0390526lld:lifeskim
pubmed-article:9648929lifeskim:mentionsumls-concept:C0074992lld:lifeskim
pubmed-article:9648929lifeskim:mentionsumls-concept:C0066772lld:lifeskim
pubmed-article:9648929pubmed:issue2lld:pubmed
pubmed-article:9648929pubmed:dateCreated1998-7-9lld:pubmed
pubmed-article:9648929pubmed:abstractTextIn Xenopus oocytes, both sphingosine-1-phosphate (S1P) and lysophosphatidic acid (LPA) activate Ca2+-dependent oscillatory Cl- currents by acting through membrane-bound receptors. External application of 50 microM S1P elicited a long-lasting oscillatory current that continued over 30 min from the beginning of oscillation, with 300 nA (n = 11) as a usual maximum peak of current, whereas 1-microM LPA treatment showed only transiently oscillating but more vigorous current responses, with 2,800 nA (n = 18) as a maximum peak amplitude. Both phospholipid-induced Ca2+-dependent Cl- currents were observed in the absence of extracellular Ca2+, were blocked by intracellular injection of the Ca2+ chelator, EGTA, and could not be elicited by treatment with thapsigargin, an inhibitor of endoplasmic reticulum (ER) Ca2+ ATPase. Intracellular Ca2+ release appeared to be from inositol 1,4,5-trisphosphate (IP3)-sensitive Ca2+ store, because Cl- currents were blocked by heparin injection. Pretreatment with the aminosteroid, U-73122, an inhibitor of G protein-mediated phospholipase C (PLC) activation, to oocytes inhibited the current responses evoked both by S1P and LPA. However, when they were injected with 10 ng of antisense oligonucleotide (AS-ODN) against Xenopus phospholipase C (PLC-xbeta), oocytes could not respond to S1P application, whereas they responded normally to LPA, indicating that the S1P signaling pathway goes through PLC-xbeta, whereas LPA signaling goes through another unknown PLC. To determine the types of G proteins involved, we introduced AS-ODNs against four types of G-protein alpha subunits that were identified in Xenopus laevis; G(q)alpha, G11alpha, G0alpha, and G(i1)alpha. Among AS-ODNs against the G alphas tested, AS-G(q)alpha and AS-G(i1)alpha to S1P and AS-G(q)alpha and AS-G11alpha to LPA specifically reduced current responses, respectively, to about 20-30% of controls. These results demonstrate that LPA and S1P, although they have similar structural features, release intracellular Ca2+ from the IP3-sensitive pool, use different components in their signal transduction pathways in Xenopus oocytes.lld:pubmed
pubmed-article:9648929pubmed:languageenglld:pubmed
pubmed-article:9648929pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9648929pubmed:citationSubsetIMlld:pubmed
pubmed-article:9648929pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9648929pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9648929pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9648929pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9648929pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9648929pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9648929pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9648929pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9648929pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9648929pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9648929pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9648929pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9648929pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9648929pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9648929pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9648929pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9648929pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9648929pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9648929pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9648929pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9648929pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9648929pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9648929pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9648929pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9648929pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9648929pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9648929pubmed:statusMEDLINElld:pubmed
pubmed-article:9648929pubmed:monthAuglld:pubmed
pubmed-article:9648929pubmed:issn0021-9541lld:pubmed
pubmed-article:9648929pubmed:authorpubmed-author:KimM BMBlld:pubmed
pubmed-article:9648929pubmed:authorpubmed-author:CoxF NFNlld:pubmed
pubmed-article:9648929pubmed:authorpubmed-author:ShimSSlld:pubmed
pubmed-article:9648929pubmed:authorpubmed-author:IlYYlld:pubmed
pubmed-article:9648929pubmed:issnTypePrintlld:pubmed
pubmed-article:9648929pubmed:volume176lld:pubmed
pubmed-article:9648929pubmed:ownerNLMlld:pubmed
pubmed-article:9648929pubmed:authorsCompleteYlld:pubmed
pubmed-article:9648929pubmed:pagination412-23lld:pubmed
pubmed-article:9648929pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:9648929pubmed:meshHeadingpubmed-meshheading:9648929-...lld:pubmed
pubmed-article:9648929pubmed:meshHeadingpubmed-meshheading:9648929-...lld:pubmed
pubmed-article:9648929pubmed:meshHeadingpubmed-meshheading:9648929-...lld:pubmed
pubmed-article:9648929pubmed:meshHeadingpubmed-meshheading:9648929-...lld:pubmed
pubmed-article:9648929pubmed:meshHeadingpubmed-meshheading:9648929-...lld:pubmed
pubmed-article:9648929pubmed:meshHeadingpubmed-meshheading:9648929-...lld:pubmed
pubmed-article:9648929pubmed:meshHeadingpubmed-meshheading:9648929-...lld:pubmed
pubmed-article:9648929pubmed:meshHeadingpubmed-meshheading:9648929-...lld:pubmed
pubmed-article:9648929pubmed:meshHeadingpubmed-meshheading:9648929-...lld:pubmed
pubmed-article:9648929pubmed:meshHeadingpubmed-meshheading:9648929-...lld:pubmed
pubmed-article:9648929pubmed:meshHeadingpubmed-meshheading:9648929-...lld:pubmed
pubmed-article:9648929pubmed:meshHeadingpubmed-meshheading:9648929-...lld:pubmed
pubmed-article:9648929pubmed:meshHeadingpubmed-meshheading:9648929-...lld:pubmed
pubmed-article:9648929pubmed:meshHeadingpubmed-meshheading:9648929-...lld:pubmed
pubmed-article:9648929pubmed:meshHeadingpubmed-meshheading:9648929-...lld:pubmed
pubmed-article:9648929pubmed:meshHeadingpubmed-meshheading:9648929-...lld:pubmed
pubmed-article:9648929pubmed:meshHeadingpubmed-meshheading:9648929-...lld:pubmed
pubmed-article:9648929pubmed:meshHeadingpubmed-meshheading:9648929-...lld:pubmed
pubmed-article:9648929pubmed:meshHeadingpubmed-meshheading:9648929-...lld:pubmed
pubmed-article:9648929pubmed:meshHeadingpubmed-meshheading:9648929-...lld:pubmed
pubmed-article:9648929pubmed:meshHeadingpubmed-meshheading:9648929-...lld:pubmed
pubmed-article:9648929pubmed:meshHeadingpubmed-meshheading:9648929-...lld:pubmed
pubmed-article:9648929pubmed:meshHeadingpubmed-meshheading:9648929-...lld:pubmed
pubmed-article:9648929pubmed:meshHeadingpubmed-meshheading:9648929-...lld:pubmed
pubmed-article:9648929pubmed:meshHeadingpubmed-meshheading:9648929-...lld:pubmed
pubmed-article:9648929pubmed:meshHeadingpubmed-meshheading:9648929-...lld:pubmed
pubmed-article:9648929pubmed:meshHeadingpubmed-meshheading:9648929-...lld:pubmed
pubmed-article:9648929pubmed:meshHeadingpubmed-meshheading:9648929-...lld:pubmed
pubmed-article:9648929pubmed:meshHeadingpubmed-meshheading:9648929-...lld:pubmed
pubmed-article:9648929pubmed:meshHeadingpubmed-meshheading:9648929-...lld:pubmed
pubmed-article:9648929pubmed:meshHeadingpubmed-meshheading:9648929-...lld:pubmed
pubmed-article:9648929pubmed:meshHeadingpubmed-meshheading:9648929-...lld:pubmed
pubmed-article:9648929pubmed:year1998lld:pubmed
pubmed-article:9648929pubmed:articleTitleDifferent signaling pathway between sphingosine-1-phosphate and lysophosphatidic acid in Xenopus oocytes: functional coupling of the sphingosine-1-phosphate receptor to PLC-xbeta in Xenopus oocytes.lld:pubmed
pubmed-article:9648929pubmed:affiliationDepartment of Life Science, Pohang University of Science and Technology, South Korea.lld:pubmed
pubmed-article:9648929pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9648929pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9648929lld:pubmed